China Oncology ›› 2022, Vol. 32 ›› Issue (6): 519-526.doi: 10.19401/j.cnki.1007-3639.2022.06.006
• Article • Previous Articles Next Articles
PANG Yi1,*()(
), WU Chunxiao1,*(
)(
), GU Kai1(
)(
), BAO Pingping1, WANG Chunfang2, SHI Liang1, GONG Yangming1, XIANG Yongmei1, DOU Jianming1, WU Mengyin1, FU Chen3, SHI Yan1
Received:
2022-01-24
Revised:
2022-05-04
Online:
2022-06-30
Published:
2022-07-21
Contact:
GU Kai
E-mail:pangyi@scdc.sh.cn;wuchunxiao@scdc.sh.cn;gukai@scdc.sh.cn
Share article
CLC Number:
PANG Yi, WU Chunxiao, GU Kai, BAO Pingping, WANG Chunfang, SHI Liang, GONG Yangming, XIANG Yongmei, DOU Jianming, WU Mengyin, FU Chen, SHI Yan. Analysis of current status of cervical cancer incidence and mortality in Shanghai, 2016 and trends of 2002-2016[J]. China Oncology, 2022, 32(6): 519-526.
Tab. 1
Cases and proportions of cervical cancer by selected diagnostic characters in Shanghai, 2002-2016"
Item | 2002—2006 | 2007—2011 | 2012—2016 | |||||
---|---|---|---|---|---|---|---|---|
Cases | Percentage/% | Cases | Percentage/% | Cases | Percentage/% | |||
Morphological verification | 1 646 | 85.68 | 3 108 | 91.36 | 4 421 | 93.19 | ||
Histological type | ||||||||
Squamous cell carcinoma | 1 162 | 60.49 | 2 303 | 67.70 | 3 206 | 67.58 | ||
Adenocarcinoma | 271 | 14.11 | 430 | 12.64 | 621 | 13.09 | ||
Others | 42 | 2.19 | 77 | 2.26 | 142 | 2.99 | ||
Unknown | 446 | 23.22 | 592 | 17.40 | 775 | 16.34 | ||
Stage | ||||||||
Ⅰ | 547 | 28.47 | 1 117 | 32.83 | 1 596 | 33.64 | ||
Ⅱ | 296 | 15.41 | 429 | 12.61 | 701 | 14.78 | ||
Ⅲ | 109 | 5.67 | 132 | 3.88 | 174 | 3.67 | ||
Ⅳ | 152 | 7.91 | 177 | 5.20 | 252 | 5.31 | ||
Unknown | 817 | 42.53 | 1 547 | 45.47 | 2 021 | 42.60 |
[1] |
FOROUZANFAR M H,, FOREMAN K J,, DELOSSANTOS A M, et al.Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis[J]. Lancet, 2011, 378(9801): 1461-1484.
doi: 10.1016/S0140-6736(11)61351-2 |
[2] |
SUNG H,, FERLAY J,, SIEGEL R L, et al.Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249.
doi: 10.3322/caac.21660 |
[3] | 孙可欣,, 郑荣寿,, 张思维, 等.2015年中国分地区恶性肿瘤发病和死亡分析[J]. 中国肿瘤, 2019, 28(1): 1-11. |
SUN K X,, ZHENG R S,, ZHANG S W, et al.Report of cancer incidence and mortality in different areas of China, 2015[J]. China Cancer, 2019, 28(1): 1-11. | |
[4] | 国家癌症中心.中国肿瘤登记工作指导手册-2016[M]. 北京:人民卫生出版社, 2016: 59-75. |
National Cancer Center.China cancer registration instruction manual-2016[M]. Beijing:People's Health Publishing House, 2016: 59-75. | |
[5] | PARKIN D M,, CHEN V W,, FERLAY J, et al.Comparability and quality control in cancer registration. IARC technical report No 19[M]. Lyon:IARC Press, 1994. |
[6] | 上海市疾病预防控制中心.上海市恶性肿瘤发病率、死亡率和生存率: 2001-2012[M].上海:上海科学普及出版社, 2017: 1-6. |
Shanghai Municipal Center for Disease Control and Prevention.Incidence rate, mortality and survival rate of malignant tumors in Shanghai: 2001-2012[M]. Shanghai:Shanghai Science Popularization Press, 2017: 1-6. | |
[7] | KURMAN R J,, CARCANGIU M L,, HERRINGTON C S, et al.WHO classification of tumours of female reproductive organs, 4th Ed, volume 6[M]. Lyon:IARC Press, 2014. |
[8] | 卢伟,, 郑莹.肿瘤命名与编码[M]. 上海:第二军医大学出版社, 2011. |
LU W,, ZHENG Y.Tumor nomenclature and coding[M]. Shanghai:the Second Military Medical University Press, 2011. | |
[9] | SEGI M. Cancer mortality for selected sites in 24 countries (1950-1957)[M].Japan:Tohoku University School of Medicine, 1960. |
[10] | Statistical Research and Applications Branch,National Cancer Institute. Joinpoint regression program, Version 4.8.0.1[CP]. April, 2020. |
[11] |
KIM H J,, FAY M P,, FEUER E J, et al.Permutation tests for joinpoint regression with applications to cancer rates[J]. Stat Med, 2000, 19(3): 335-351.
doi: 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z |
[12] | FERLAY J,, ERVIK M,,LAM F,et al. Global cancer observatory: cancer today[DB/OL]. Lyon, France:International Agency for Research on Cancer.https://gco.iarc.fr/today, accessed. |
[13] | 《上海卫生志》编纂委员会.上海卫生志[M]. 上海:上海社会科学院出版社, 1998. |
Compilation Committee of Shanghai Health Records.Shanghai Journal of Health[M]. Shanghai:Shanghai Academy of Social Sciences Press, 1998. | |
[14] |
HUANG Z Z,, ZHENG Y,, WEN W Q, et al.Incidence and mortality of gynaecological cancers: secular trends in urban Shanghai, China over 40 years[J]. Eur J Cancer, 2016, 63: 1-10.
doi: 10.1016/j.ejca.2016.04.016 |
[15] | ZHANG S W,, SUN K X,, ZHENG R S, et al.Cancer incidence and mortality in China, 2015[J]. J Natl Cancer Cent, 2021, 1(1): 2-11. |
[16] |
HENLEY S J,, WARD E M,, SCOTT S, et al.Annual report to the nation on the status of cancer, part Ⅰ: national cancer statistics[J]. Cancer, 2020, 126(10): 2225-2249.
doi: 10.1002/cncr.32802 |
[17] | International Agency for Research on Cancer. Cervix cancer screening. IARC handbooks of cancer prevention.Volume 10[M]. Lyon:IARC Press, 2005. |
[18] |
WALBOOMERS J M,, JACOBS M V,, MANOS M M, et al.Human papillomavirus is a necessary cause of invasive cervical cancer worldwide[J]. J Pathol, 1999, 189(1): 12-19.
doi: 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F |
[19] |
BRAY F,, LOOS A H,, MCCARRON P, et al.Trends in cervical squamous cell carcinoma incidence in 13 European countries: changing risk and the effects of screening[J]. Cancer Epidemiol Biomarkers Prev, 2005, 14(3): 677-686.
doi: 10.1158/1055-9965.EPI-04-0569 |
[20] |
UTADA M,, CHERNYAVSKIY P,, LEE W J, et al.Increasing risk of uterine cervical cancer among young Japanese women: comparison of incidence trends in Japan, South Korea and Japanese-Americans between 1985 and 2012[J]. Int J Cancer, 2019, 144(9): 2144-2152.
doi: 10.1002/ijc.32014 |
[21] |
ZHAO F H,, LEWKOWITZ A K,, HU S Y, et al.Prevalence of human papillomavirus and cervical intraepithelial neoplasia in China: a pooled analysis of 17 population-based studies[J]. Int J Cancer, 2012, 131(12): 2929-2938.
doi: 10.1002/ijc.27571 |
[22] |
LI J,, HUANG R,, SCHMIDT J E, et al.Epidemiological features of human papillomavirus (HPV) infection among women living in Mainland China[J]. Asian Pac J Cancer Prev, 2013, 14(7): 4015-4023.
doi: 10.7314/APJCP.2013.14.7.4015 |
[23] | 李新建,,徐继英,卢伟主编. 上海市疾病预防控制中心编著.上海市慢性病及其危险因素监测报告-2007[M]. 上海:上海科学普及出版社, 2012. |
LI J X,, XU J Y,LU W editor in chief. Edited by Shanghai Center for Disease Control and Prevention. Surveillance report on chronic diseases and their risk factors in Shanghai- 2007[M]. Shanghai:Shanghai Science Popularization Press, 2012. | |
24. | 李新建,,徐继英,,仲伟鉴主编. 上海市疾病预防控制中心编著.上海市慢性病及其危险因素监测报告-2010[M]. 上海:上海科学普及出版社, 2012. |
LI J X,, XU J Y,,ZHONG W J editor in chief. Edited by Shanghai Center for Disease Control and Prevention. Surveillance report on chronic diseases and their risk factors in Shanghai- 2010[M]. Shanghai:Shanghai Science Popularization Press, 2012. | |
25. | 上海市疾病预防控制中心.上海市慢性病及其危险因素监测报告-2013[M]. 上海:上海科学普及出版社, 2014. |
Shanghai Municipal Center for Disease Control and Prevention.Surveillance report on chronic diseases and their risk factors in Shanghai-2013[M]. Shanghai:Shanghai Science Popularization Press, 2014. | |
26. | World Health Organization.WHO director-general calls for all countries to take action to help end the suffering caused by cervical cancer[EB/OL]. WHO, 2018. [2021-07-15]who.int/reproductivehealth/call-to-action-elimination-cervical-cancer/en/. |
27. | 张韶凯,, 赵方辉,, 乔友林.中国宫颈癌防治研究20年历程与成就[J]. 中华流行病学杂志, 2020, 41(6): 809-812. |
ZHANG S K,, ZHAO F H,, QIAO Y L.Development and achievements regarding the prevention and control of cervical cancer in the last 20 years in China[J]. Chin J Epidemiol, 2020, 41(6): 809-812. | |
28. |
FORCE U P S T,, CURRY S J,, KRIST A H, et al.Screening for cervical cancer: US preventive services task force recommendation statement[J]. JAMA, 2018, 320(7): 674-686.
doi: 10.1001/jama.2018.10897 |
29. | 黄留叶,, 赵雪莲,, 赵方辉.宫颈癌的发病与死亡变化趋势及其预防策略进展[J]. 肿瘤综合治疗电子杂志, 2021, 7(2): 21-25. |
HUANG L Y,, ZHAO X L,, ZHAO F H.Trend of cervical cancer incidence, mortality, and progress of prevention strategies[J]. J Multidiscip Cancer Manag Electron Version, 2021, 7(2): 21-25. | |
[30] | 彭鹏,, 鲍萍萍,, 王春芳, 等.上海市女性居民宫颈癌筛查知识和行为现状调查[J]. 环境与职业医学, 2014, 31(5): 342-346. |
PENG P,, BAO P P,, WANG C F, et al.Knowledge and behavior of female residents in Shanghai regarding cervical cancer screening[J]. J Environ Occup Med, 2014, 31(5): 342-346. | |
[31] | 任文辉,, 赵艳霞,, 马兰, 等.我国贫困地区宫颈癌筛查效果及影响因素研究[J]. 中国妇产科临床杂志, 2020, 21(4): 388-391. |
REN W H,, ZHAO Y X,, MA L, et al.Influencing factors of the quality of cervical cancer screening in poverty-stricken counties in China[J]. Chin J Clin Obstet Gynecol, 2020, 21(4): 388-391. | |
[32] |
黄静,, 杨湘红,, 刘爱, 等.农村地区妇女“两癌筛查”项目实施中的问题与对策[J]. 中国全科医学, 2020, 23(13): 1680-1686.
doi: 10.12114/j.issn.1007-9572.2019.00.509 |
HUANG J,, YANG X H,, LIU A, et al.Problems and countermeasures in the implementation of national cervical and breast screening program for women in rural areas[J]. Chin Gen Pract, 2020, 23(13): 1680-1686. | |
[33] | 吴春晓,, 郑莹.《上海市肿瘤登记管理办法》解读[J]. 上海预防医学, 2017, 29(7): 523-524. |
WU C X,, ZHENG Y.Interpretation of Shanghai tumor registration management measures[J]. Shanghai J Prev Med, 2017, 29(7): 523-524. |
[1] | CHEN Xun, ZHENG Zhenxia, RUAN Xueru. Effects of TMCO1 on proliferation and migration of cervical cancer cells [J]. China Oncology, 2024, 34(6): 571-580. |
[2] | FENG Zheng, GUO Qinhao, ZHU Jun, WU Xiaohua, WEN Hao. Progress in treatment of gynecological cancer in 2023 [J]. China Oncology, 2024, 34(4): 340-360. |
[3] | SHEN Jie, FENG Xiaoshuang, WEN Hao, ZHOU Changming, MO Miao, WANG Zezhou, YUAN Jing, WU Xiaohua, ZHENG Ying. Metastasis patterns and survival analysis of 572 patients with metastatic cervical cancer: a hospital-based real world study [J]. China Oncology, 2024, 34(4): 361-367. |
[4] | ZHOU Changming, WANG Zezhou, ZHENG Ying. Interpretation of US cancer statistics 2023 and its implications for cancer prevention and treatment in China [J]. China Oncology, 2023, 33(2): 117-125. |
[5] | XIA Lingfang, ZHU Jun, WU Xiaohua. The latest progress and prospect of gynecological tumor treatment at 2023 ESMO [J]. China Oncology, 2023, 33(11): 969-980. |
[6] | GUO Qinhao, YU Min, WU Xiaohua. Progress in diagnosis and treatment of gynecological tumors in 2022 [J]. China Oncology, 2023, 33(1): 14-24. |
[7] | WANG Chuntao, GE Anxing, WU Hongyan, ZHANG Xueyan, YANG Sheng, YUAN Hongxiang, CHENG Yanping, FENG Yanlu, LU Xinyuan, LIANG Geyu. The association between cervical lesions of different grades and lncRNA HOTTIP and H19 single nucleotide polymorphisms [J]. China Oncology, 2022, 32(4): 324-334. |
[8] | WU Mengyin, WU Chunxiao, PANG Yi, WANG Chunfang, GU Kai, GONG Yangming, BAO Pingping, SHI Liang, DOU Jianming, XIANG Yongmei, SHI Yan. Incidence and mortality of pancreatic cancer in Shanghai 2016 and epidemic trend analysis from 2002 to 2016 [J]. China Oncology, 2022, 32(2): 97-105. |
[9] | FANG Yanhui , MA Caijuan , ZHANG Chunli , ZHAI Jiawei , ZHU Qiaoying , LIU Yin , ZHAO Xiwa . miR-496 inhibits proliferation, migration and invasion of HeLa cell in cervical cancer via SFMBT1 [J]. China Oncology, 2021, 31(8): 697-703. |
[10] | LONG Xingtao , ZHOU Qi , WANG Dong , CHEN Yuemei , JIN Fujun . The prognostic value of revised 2018 FIGO stage ⅢC in cervical cancer [J]. China Oncology, 2021, 31(8): 725-733. |
[11] | DONG Shijie, HU Xiaoxin, WANG Wei, YANG Meng, YUE Lei, TONG Tong, GU Yajia. Prediction of lymph node metastasis of cervical cancer based on multi-sequence MRI and multi-system imaging omics model [J]. China Oncology, 2021, 31(6): 460-467. |
[12] | ZHANG Jian , SHEN Weina , JI Dongmei , WANG Leiping , GONG Chengcheng , HU Xichun . FUSCC criteria for the management of targeted drug-induced interstitial lung disease in solid tumors [J]. China Oncology, 2021, 31(4): 241-249. |
[13] | ZHU Jun, WU Xiaohua. Leading research progress and prospect of gynecological oncology in 2020 [J]. China Oncology, 2021, 31(4): 250-256. |
[14] | LU Ming, HONG Yuming, ZHENG Chaohui, CHEN Xiaofang, LIANG Zhenyuan. Factors influencing postoperative hypercoagulability of free flap reconstruction for head and neck tumor [J]. China Oncology, 2021, 31(4): 317-322. |
[15] | WU Chunxiao , GU Kai , PANG Yi , BAO Pingping , WANG Chunfang , SHI Liang , GONG Yangming , XIANG Yongmei , DOU Jianming , SHI Yan , FU Chen . Analysis of the current status of cancer incidence and mortality in Shanghai, 2016 and trends of 2002-2016 [J]. China Oncology, 2021, 31(10): 879-891. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||
沪ICP备12009617
Powered by Beijing Magtech Co. Ltd